Abiopharma

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort

New Form 8-K - Roivant Sciences Ltd. Filed: 2025-06-25 AccNo: 0001140361-25-023553 Size: 155 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Arbutus Biopharma Corp Filed: 2025-06-25 AccNo: 0001171843-25-004094 Size: 270 KB Item 1.02: Termination of a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form F-3ASR - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-06-25 AccNo: 0001395064-25-000097 Size: 1 MB

Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results

Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus

Ionis announces Biogen to advance salanersen into SMA registrational studies based on positive interim Phase 1 results

Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer

Oncotelic Therapeutics Announces Publication of Landmark Study on TGFB2 Gene Methylation as a Positive Prognostic Marker in Pancreatic Cancer

New Form 424B3 - PORTAGE BIOTECH INC. Filed: 2025-06-25 AccNo: 0001171843-25-004093 Size: 26 KB

New Form 6-K - PORTAGE BIOTECH INC. Filed: 2025-06-25 AccNo: 0001171843-25-004092 Size: 16 KB

New Form 8-K - Kymera Therapeutics, Inc. Filed: 2025-06-25 AccNo: 0001193125-25-146135 Size: 171 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Kymera Therapeutics, Inc. Filed: 2025-06-25 AccNo: 0001193125-25-146134 Size: 203 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Kymera Therapeutics Announces Sanofi IRAK4 Collaboration Update